Skip to main content

Table 1 Clinicopathologic characteristics of IPO5 expression in CRC patients

From: IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation

Clinicopathological
Variables
All cases
N 100 High expression
53
Low Expression
47
X 2 P
Age (years)
 ≤ 60 48 26 22 0.050 0.49
 > 60 52 27 25   0
Gender
 Male 56 28 28 0.460  
 Female 44 25 19   0.549
Tumor size (cm)
 ≤ 4.75 49 21 28 3.968  
 > 4.75 51 32 19   0.036
Differentiation
 Well 20 7 13 7.647  
 Moderate 61 30 31   0.020
 Poor 19 16 3   
Serosal invasion
 Yes 40 20 20 0.241  
 No 60 33 27   0.387
Lymph metastasis
 Yes 45 30 15 10.389  
 No 55 23 32   0.006
TNM classification
 I–II 65 29 36 10.585  
 III–IV 35 24 11   0.014